Skip to content

Alto Neuroscience ANRO Change in other, net

Change in other, net at other companies

Pitney Bowes logo
Pitney BowesPBI
$11.84M+148%
Scotts Miracle-Gro logo
Scotts Miracle-GroSMG
$4.3M+438%
Flagstar Bank
 logo
Flagstar Bank FLG
-$35M-284%
Kemper logo
KemperKMPR
$22M+523%
HWK
HawkinsHWKN
-$1.45M
Whirlpool logo
WhirlpoolWHR
$132M+46.7%

Other financials

Income statement

See full
Operating income-$27.1M-73.1%
Net income-$26.2M-73.0%
EPS (diluted)-$0.80-42.9%

Balance sheet

See full
Cash & equivalents$264.3M+63.9%
Total debt$20.9M-17.2%
Total equity$243.4M+75.0%
Total assets$276.3M+60.7%

Cash flow

See full
Operating cash flow-$27.1M-63.6%
CapEx$556.0K+2,217%
Free cash flow-$27.6M-66.7%

Valuation

See full
Market cap$887.88M+1,358%
Enterprise value$644.49M-958%

Returns & leverage

See full
Return on equity-38.9%+0.9pp
Debt / equity0.1×-0.1×
Current ratio20.5×-2.0×

Where this comes from

Reported directly by Alto Neuroscience in its filing.

Tagged under the XBRL concept alto:GainLossInOtherOperatingActivitiesNet.

The official record: Alto Neuroscience’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alto Neuroscience's change in other, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Alto Neuroscience's change in other, net?
Alto Neuroscience (ANRO) reported change in other, net of $116K in Q1 2026.
How has Alto Neuroscience's change in other, net changed year-over-year?
Alto Neuroscience's change in other, net increased by 182.9% year-over-year, from $41K to $116K.
What does change in other, net mean?
Captures the net impact of miscellaneous operating activities that do not fall under standard line items like depreciation or stock-based compensation. This metric aggregates minor adjustments to operating cash flow, providing a comprehensive view of operational volatility. It serves as a catch-all for non-recurring or secondary operational adjustments.